Prevalence of Hidradenitis Suppurativa

作者：Dorra Bouazzi, Sabrina Mai Nielsen, Paa Gyasi Hagan, Sofia Botvid, Lone Storgaard Hove, Errol P. Prens, Robin Christensen, Gregor B. E. Jemec, GHiSA Group, Klaudia Knecht-Gurwin, Jacek C. Szepietowski, Ehiaghe L. Anaba, A.S. Chehad, S. Zobiri, A. Serradj, Mohammed Saiful Islam Bhuiyan, Towhida Noor, Philippe Guillem, Mohammad Mahdi Parvizi, Nasrin Saki, Erkan Alpsoy, Caner Vardar, Theodora Kanni, Evangelos J. Giamarellos‐Bourboulis, John W. Frew, Waleed H. A. Al Maharbi, Johanna C. van Huijstee, Pim Aarts, Shinta Trilaksmi Dewi, Sri Awalia Febriana, Niken Indrastuti, Nyoman Suryawati, Miranti Pangastuti, Aryani Adji, Gardenia Akhyar, Nopriyati Nopriyati, Cut Putri Hazlianda, Francisco Reyes‐Baraona, Carlos Matas, Haroon Saeed, Ameshin Moodley, Yousef Binamer, Moonyza Akmal Ahmad Kamil, Ivana Jocic, Željko Mijušković, Kanchana Mallawaarachchi, Chathurika Gangani, Ivana Tusheva, Vesna Brishkoska Boshkovski, Danchen Hu, Songmei Geng, Cecilia E. Medianfar, Ditte Marie Lindhardt Saunte, Nisha Suyien Chandran, Hessel H. van der Zee, Christos C. Zouboulis, Farida Benhadou, Bente Villumsen, Afsáneh Alavi, Perpetua U. Ibekwe, Iltefat Hamzavi, John R Ingram, Haley B. Naik, Amit Garg, Jurr Boer · 发表于：JAMA Dermatology · 年份：2025 · DOI：10.1001/jamadermatol.2025.2373 · 被引用次数：22 · 研究领域：Hidradenitis Suppurativa and Treatments、Acne and Rosacea Treatments and Effects、Dermatological and COVID-19 studies

Importance: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a substantial burden. Standardized global prevalence estimates and data on associated sociodemographic and risk factors are lacking. Objective: To estimate the global prevalence of HS and study differences in prevalence by age, sex, geographical location, body mass index (BMI; calculated as weight in kilograms divided by height in meters squared), smoking status, gross domestic product (GDP), and Human Development Index (HDI). Data Sources and Study Selection: Included studies were conducted using the standardized Global Hidradenitis Suppurativa Atlas methodology with finalized data collection before May 19, 2023. Studies were required to use a population-based sampling method and conduct clinical confirmation of HS diagnosis following a screening questionnaire. Data Extraction and Synthesis: Data were independently extracted from relevant studies by 2 reviewers (D.B. and C.E.M.) using a standardized form. Extracted variables included geographic location, age, sex, BMI (median and BMI >30), smoking status, HS prevalence estimates (with 95% CIs), GDP, and HDI. A proportional meta-analysis using a random-effects model was conducted on the included studies. Main Outcomes and Measures: The primary outcome was the point prevalence of HS, confirmed by clinical examination. Secondary outcomes included differences in HS prevalence by sex, age, BMI category, smoking status, and country-level socioeco...